LEMAITRE VASCULAR INC

LEMAITRE VASCULAR INC is a global provider of medical devices and human tissue cryopreservation services primarily used in treating peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices for vascular surgeons and, to a lesser extent, cardiac surgeons, general surgeons, and neurosurgeons. Its diverse portfolio includes brand name products for use in arteries and veins, which are recognized by vascular surgeons. LEMAITRE VASCULAR INC's main product offerings are sold globally, with primary markets in the United States, Europe, Canada, and Asia Pacific. The company estimates the annual worldwide market for peripheral vascular devices exceeds $9 billion, with the market for its specific products estimated at approximately $1 billion. Sales are primarily conducted through a direct sales force. The company's worldwide headquarters is in Burlington, Massachusetts, with a North American sales office in Vaughan, Canada. Its European headquarters is in Sulzbach, Germany, supported by sales offices in Milan, Italy; Madrid, Spain; Hereford, England; Dublin, Ireland; Maisons-Alfort, France; and Glattbrugg, Switzerland. The Asia Pacific headquarters is in Singapore, with sales offices in Tokyo, Japan; Shanghai, China; Docklands, Australia; Seoul, Korea; and Bangkok, Thailand. For the year ended December 31, 2025, approximately 95% of net sales came from territories with direct sales representatives. Products are also sold through distributors in other countries. As of December 31, 2025, the sales force included 160 sales representatives and export managers across North America, Europe, and Asia Pacific. Peripheral vascular disease affects over 200 million people worldwide.